Enorama Pharma AB (ERMA)
Market Closed
15 Oct, 03:25 PM
XSTO XSTO Primary kr
1. 19
+0.46
+62.3288%
kr
237.06M Market Cap
- P/E Ratio
- Div Yield
685,224 Volume
0 Eps
kr 0.73
Previous Close Want to track ERMA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Enorama Pharma AB (ERMA) Statistics
Valuation metrics
Market Cap 237.06M
Enterprise value 44.74M
Trailing P/E (ttm) -0.78
Forward P/E -
PEG ratio -0.02
Price/Sales (ttm) 32.35
Price/Book (mrq) -0.93
Enterprise Value/Revenue 30.9
Enterprise Value/EBITDA -0.83
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 4.04K
Average volume (90 days) 174.87K
Price summary
52-Week low 0.21
52-Week high 3.58
Beta -
50-Day moving average 0.74
200-Day moving average 0.46
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -41.22%
Operating margin -37.58%
Operational effectiveness
Return on assets -8.58%
Return on equity 2.07%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.02
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.8
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.03
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 0.21%
Book value per share (mrq) -0.68
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
